Cordner, Ryan
Jhun, Michelle
Panwar, Akanksha
Wang, HongQiang
Gull, Nicole
Murali, Ramachandran
McAbee, Joseph H. http://orcid.org/0000-0002-1711-1706
Mardiros, Armen
Sanchez-Takei, Akane
Mazer, Mia W.
Fan, Xuemo
Jouanneau, Emmanuel
Yu, John S.
Black, Keith L.
Wheeler, Christopher J. http://orcid.org/0000-0003-0618-8748
Funding for this research was provided by:
Research support was provided by a grant from the Joseph Drown Foundation (CJW), and by the Maxine-Dunitz Neurosurgical Institute.
Article History
Received: 9 December 2017
Revised: 26 April 2023
Accepted: 28 April 2023
First Online: 9 May 2023
Competing interests
: Authors RC, KLB, and CJW were co-authors on a provisional patent, “IDH1 as a biomarker and enhancer of cancer immunotherapy”. Application no. 62/586,408. A non-provisional patent was not submitted, and no financial support has been received in association with the earlier application. Although all the work was done at Cedars-Sinai Medical Center, CJW is now President and a paid employee of StemVax Therapeutics, a wholly owned subsidiary of NovAccess Global that is commercializing dendritic cell vaccines for malignant glioma patients. The other authors declare no competing interests.